A gentler chemo schedule may match standard care in advanced pancreatic cancer
A systematic review of five real-world studies finds that a biweekly gemcitabine and nab-paclitaxel schedule matches standard survival outcomes in ...
A systematic review of five real-world studies finds that a biweekly gemcitabine and nab-paclitaxel schedule matches standard survival outcomes in ...
Adding nanoparticle albumin-bound paclitaxel to transarterial chemoembolization significantly improved disease control and sharply reduced tumor progression in breast cancer liver ...
A new meta-analysis finds that cooling gloves and socks during paclitaxel chemotherapy significantly reduce sensory nerve damage in breast cancer ...
A prospective Phase II trial in Japan found that biweekly gemcitabine plus nab-paclitaxel produced a 47.1 percent response rate and ...
The phase 1 GlutaPanc trial shows that l-glutamine can be safely combined with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine